Consolidated 3-year work plan for the Emergency Task Force (ETF)
Consolidated 3-year work plan for the Emergency Task Force (ETF)
Consolidated 3-year work plan for the Emergency Task Force (ETF)
Goodbye 2023: when optimism came back
Request a change of the applicant for an ongoing marketing authorisation application
List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)
Biologicals: finished product
Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, Amsterdam, the Netherlands, 26 November 2018
Human medicines European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan), clopidogrel, Date of authorisation: 21/09/2009, Revision: 21, Status: Authorised
Notification of discontinuation of an agreed PIP decision
Scientific advice and protocol assistance adopted during the CHMP meeting 11-14 December 2023
Member states contact points for translations review